Xiaoli Cheng

712 total citations
37 papers, 406 citations indexed

About

Xiaoli Cheng is a scholar working on Molecular Biology, Complementary and alternative medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoli Cheng has authored 37 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Complementary and alternative medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoli Cheng's work include Traditional Chinese Medicine Analysis (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Autophagy in Disease and Therapy (3 papers). Xiaoli Cheng is often cited by papers focused on Traditional Chinese Medicine Analysis (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Autophagy in Disease and Therapy (3 papers). Xiaoli Cheng collaborates with scholars based in China, Australia and Canada. Xiaoli Cheng's co-authors include Chenghui Yan, Xiaoxiang Tian, Haixu Song, Naotaka Hamasaki, Ryu Takeya, Atsushi Fukuoh, Tomotake Kanki, Dongchon Kang, Kippei Ohgaki and Yoshimasa Aoki and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and BioMed Research International.

In The Last Decade

Xiaoli Cheng

35 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Cheng China 14 211 62 47 38 37 37 406
Tz‐Chong Chou Taiwan 15 227 1.1× 80 1.3× 39 0.8× 34 0.9× 27 0.7× 20 608
Meng Gao China 13 214 1.0× 57 0.9× 23 0.5× 62 1.6× 41 1.1× 31 486
Meizhu Wu China 13 268 1.3× 72 1.2× 81 1.7× 28 0.7× 29 0.8× 43 452
Nuno G. Machado Portugal 11 208 1.0× 61 1.0× 76 1.6× 49 1.3× 49 1.3× 12 428
V. Vijaya Padma India 14 233 1.1× 77 1.2× 91 1.9× 33 0.9× 53 1.4× 21 478
Fenghao Geng China 10 173 0.8× 48 0.8× 36 0.8× 60 1.6× 38 1.0× 21 388
Qiong Lai China 12 232 1.1× 55 0.9× 60 1.3× 31 0.8× 56 1.5× 19 389
Chan Wu China 13 301 1.4× 38 0.6× 30 0.6× 31 0.8× 32 0.9× 24 490
Fengxia Lin China 10 216 1.0× 106 1.7× 36 0.8× 39 1.0× 30 0.8× 21 380
Yang Jie-ren China 16 178 0.8× 31 0.5× 44 0.9× 32 0.8× 42 1.1× 27 536

Countries citing papers authored by Xiaoli Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Cheng more than expected).

Fields of papers citing papers by Xiaoli Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Cheng. The network helps show where Xiaoli Cheng may publish in the future.

Co-authorship network of co-authors of Xiaoli Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Cheng. A scholar is included among the top collaborators of Xiaoli Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Cheng. Xiaoli Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Dan, Xiaoli Cheng, Haixu Song, et al.. (2024). CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes. Redox Biology. 75. 103293–103293. 15 indexed citations
2.
Zhu, Lin, Yijuan Xin, Mu He, et al.. (2024). Downregulation of miR‐337‐3p in hypoxia/reoxygenation neuroblastoma cells increases KCTD11 expression. Journal of Biochemical and Molecular Toxicology. 38(4). e23685–e23685. 1 indexed citations
3.
Feng, Qingchuan, et al.. (2021). Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis. General Physiology and Biophysics. 40(1). 31–48. 3 indexed citations
4.
Cheng, Xiaoli, et al.. (2021). Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity. Biochemical and Biophysical Research Communications. 550. 142–150. 31 indexed citations
5.
Liu, Dan, Xiaoxiang Tian, Yanxia Liu, et al.. (2021). CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42. Cell Death and Disease. 12(4). 355–355. 10 indexed citations
6.
Cheng, Xiaoli, et al.. (2020). Orosomucoid 1 Attenuates Doxorubicin‐Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling. BioMed Research International. 2020(1). 5923572–5923572. 17 indexed citations
7.
Cheng, Xiaoli, et al.. (2020). SPR immunosensor combined with Ti4+@TiP nanoparticles for the evaluation of phosphorylated alpha-synuclein level. Microchimica Acta. 187(9). 509–509. 13 indexed citations
8.
Cheng, Xiaoli, Hanxiang Li, Juan Chen, et al.. (2020). Bioactive Diarylheptanoids from Alpinia coriandriodora. Natural Products and Bioprospecting. 11(1). 63–72. 12 indexed citations
9.
Cheng, Xiaoli, et al.. (2020). 18α-Glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation. Biomedicine & Pharmacotherapy. 125. 109702–109702. 22 indexed citations
10.
Cheng, Xiaoli, et al.. (2019). The HO-1-expressing bone mesenchymal stem cells protects intestine from ischemia and reperfusion injury. BMC Gastroenterology. 19(1). 124–124. 11 indexed citations
11.
Cheng, Xiaoli, et al.. (2019). Low-dose nicotine promotes autophagy of cardiomyocytes by upregulating HO-1 expression. Biochemical and Biophysical Research Communications. 522(4). 1015–1021. 13 indexed citations
13.
Cheng, Xiaoli, et al.. (2016). Phenotype and genotype analysis of in herited dysplasminogenemia caused by plasminogen Ala601Thr mutation. Zhonghua jianyan yixue zazhi. 39(5). 366–371. 1 indexed citations
15.
Jiang, Cong, et al.. (2014). HIGH-EFFICIENCY TRANSFORMATION OF THE PLANT PATHOGENIC FUNGUS MARSSONINA BRUNNEA. Journal of Plant Pathology. 96(3). 459–464. 2 indexed citations
16.
Lu, Li, Rahul Deshmukh, Jie Long, et al.. (2014). Tumor Necrosis Factor-α Sensitizes Breast Cancer Cells to Natural Products with Proteasome-Inhibitory Activity Leading to Apoptosis. PLoS ONE. 9(11). e113783–e113783. 28 indexed citations
17.
Liu, Yongqi, et al.. (2014). Tumor Inhibition Effects and Mechanisms of Angelica sinensis and Sophorae flavescentis ait Decoction Combined with Cisplatin in Xenograft Mice. Asian Pacific Journal of Cancer Prevention. 15(11). 4609–4615. 6 indexed citations
18.
Cheng, Xiaoli. (2012). Comparison of PBL and LBL in the teaching of the design of pharmaceutical formulation. 1 indexed citations
19.
Liu, Ying, et al.. (2012). [Mechanism of genuineness of liquorice Glycyrrhiza uralensis based on CNVs of HMGR, SQS1 and beta-AS gene].. PubMed. 47(2). 250–5. 4 indexed citations
20.
Cheng, Xiaoli, Tomotake Kanki, Atsushi Fukuoh, et al.. (2005). PDIP38 Associates with Proteins Constituting the Mitochondrial DNA Nucleoid. The Journal of Biochemistry. 138(6). 673–678. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026